Solved

Rosh Pharmaceuticals Corp

Question 49

Multiple Choice

Rosh Pharmaceuticals Corp.is based in Israel but it maintains intellectual property protection of all its drugs with the Canadian Patent Office.If insufficient quantities of Rosh Pharmaceuticals Corp.'s newly patented pancreatic cancer drug are produced to meet demand in Canada,which of the following is most likely to be the result?


A) loss of intellectual property rights
B) licence to a Canadian facility
C) assignment to a Canadian facility
D) assignment of patent rights

Correct Answer:

verifed

Verified

Unlock this answer now
Get Access to more Verified Answers free of charge

Related Questions

Unlock this Answer For Free Now!

View this answer and more for free by performing one of the following actions

qr-code

Scan the QR code to install the App and get 2 free unlocks

upload documents

Unlock quizzes for free by uploading documents